Tyra Biosciences, Inc.TYRANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+23.3%
5Y CAGR+70.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+23.3%/yr
Annual compound
5Y CAGR
+70.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
14.2x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$29.83M+23.8%
2024$24.10M+38.3%
2023$17.43M+9.5%
2022$15.92M+181.7%
2021$5.65M+169.9%
2020$2.09M+57.2%
2019$1.33M-